NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Upfront Diagnostics

Upfront Diagnostics

Private
CambridgeHealthcare & Life Scienceshttps://upfrontdiagnostics.com/

Last Round

Grant

Jul 1, 2026

Total Funding Raised

$3.9M

Company Overview

Upfront Diagnostics is a biotechnology company that develops rapid point-of-care diagnostic tests for stroke detection.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

point-of-care diagnosticsPOC diagnosticsstroke triagelarge vessel occlusionLVOmedical devicepre-hospital carelateral-flow assayrapid diagnostic teststroke careemergency medical servicesEMSbiomarker testingbedside testingmedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Upfront Diagnostics Comparables

Compare Upfront Diagnostics with similar companies based on industry and business-model similarity.

Upfront Diagnostics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ABCDx
88%
Galaxy CCRO, Inc.
78%
Sense Neuro Diagnostics
77%

Upfront Diagnostics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJul 1, 2026
GrantJun 21, 2025
VC RoundMay 12, 2025
GrantMar 17, 2025
GrantJun 27, 2023
Seed
Jun 27, 2023

Key People

Founding team and executive leadership

Gonzalo Ladreda

CEO Co Founder

Founding Team

Upfront Diagnostics Investors

Notable investors and investment history

Upfront Diagnostics investors
InvestorRounds
Cambridge Enterprise VenturesVC Round
SBRI HealthcareSeed, Grant, VC Round
Centre for Process InnovationGrant
APEX VenturesSeed
Stroke AssociationSeed, Grant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 22, 2025

    Attending the 17th World Stroke Congress in Barcelona, October 22-24, 2025.

  • Oct 14, 2025

    Launched LVOne, a rapid point-of-care blood test for stroke triage.

Upfront Diagnostics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Upfront Diagnostics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Upfront Diagnostics's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge
Employee Range9
Year Founded2017
Last FundingJul 1, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.